Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) VP John D. Quisel unloaded 9,000 shares of Acceleron Pharma stock on the open market in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $33.94, for a total value of $305,460.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of Acceleron Pharma (NASDAQ:XLRN) traded up 3.71% on Tuesday, hitting $34.10. The stock had a trading volume of 360,209 shares. Acceleron Pharma has a 52 week low of $16.78 and a 52 week high of $57.89. The stock’s 50-day moving average is $31.91 and its 200-day moving average is $37.89. The company’s market cap is $1.073 billion.

Acceleron Pharma (NASDAQ:XLRN) last released its earnings data on Thursday, May 15th. The company reported ($0.30) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.44) by $0.14. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million. Analysts expect that Acceleron Pharma will post $-1.24 EPS for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.